Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Aug;310(2):769-781.
doi: 10.1007/s00404-023-07346-5. Epub 2024 Jan 18.

Effect of probiotics on pregnancy outcomes in gestational diabetes: systematic review and meta-analysis

Rui Wu  1 , Jiasi Luan  2 , Juanjuan Hu  1 , Zuojing Li  3
Affiliations
Meta-Analysis

Effect of probiotics on pregnancy outcomes in gestational diabetes: systematic review and meta-analysis

Rui Wu et al. Arch Gynecol Obstet. 2024 Aug.

Abstract

Objective: Gestational diabetes mellitus (GDM) is a prevalent complication during pregnancy associated with numerous adverse outcomes. There is emerging evidence suggesting the potential of probiotics as a therapeutic measure for GDM; however, existing studies have yielded contradictory results. This meta-analysis assessed the efficacy of probiotics on blood glucose management and pregnancy outcomes in patients with GDM.

Methods: A comprehensive search of the PubMed, Embase, and Cochrane databases was conducted up to August 22, 2023, to identify relevant studies. The primary outcomes focused on fasting blood glucose (FBG), fasting serum insulin (FSI), homeostasis model assessment of insulin resistance (HOMA-IR), and quantitative insulin sensitivity check index (QUICKI). The secondary outcomes included various maternal and neonatal outcomes.

Results: This meta-analysis included 15 randomized controlled trials (RCTs), encompassing 1006 patients with GDM. The results showed that, compared to a placebo, probiotics demonstrated a significant reduction in FBG (MD - 2.58, 95% CI - 4.38 to - 0.79, p < 0.01), FSI (MD - 2.29, 95% CI - 3.40 to - 1.18, p < 0.01), HOMA-IR (MD - 0.56, 95% CI - 0.81 to - 0.32, p < 0.01), and birth weight (MD - 101.20, 95% CI - 184.62 to - 17.77, p = 0.02). Furthermore, it resulted in fewer neonatal intensive care unit (NICU) admissions (RR 0.60, 95% CI 0.40-0.89, p = 0.01), instances of hyperbilirubinemia (RR 0.31, 95% CI 0.16-0.61, p < 0.01), and elevated QUICKI (MD 0.01, 95% CI 0.00-0.01, p < 0.01). No significant impact was observed in the other analyzed outcomes.

Conclusions: In conclusion, probiotics improve FBG, FSI, and HOMA-IR, and reduce the occurrence of neonatal hyperbilirubinemia, NICU admissions, and birth weight in the offspring of patients with GDM. However, the quality of the evidence, as per the GRADE approach, varies from high to low, necessitating further studies to consolidate these findings.

Keywords: GDM; Gestational diabetes; Meta-analysis; Pregnancy; Probiotics.

PubMed Disclaimer

References

    1. Szmuilowicz ED, Josefson JL, Metzger BE (2019) Gestational diabetes mellitus. Endocrinol Metab Clin N Am 48(3):479–493. https://doi.org/10.1016/j.ecl.2019.05.001 - DOI
    1. Lowe WL Jr, Scholtens DM, Lowe LP, Kuang A, Nodzenski M, Talbot O et al (2018) Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 320(10):1005–1016. https://doi.org/10.1001/jama.2018.11628 - DOI - PubMed - PMC
    1. Alfadhli EM (2015) Gestational diabetes mellitus. Saudi Med J 36(4):399–406. https://doi.org/10.15537/smj.2015.4.10307 - DOI - PubMed - PMC
    1. Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA (2017) Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev 11(11):Cd012037. https://doi.org/10.1002/14651858.CD012037.pub2 - DOI - PubMed
    1. Suez J, Zmora N, Segal E, Elinav E (2019) The pros, cons, and many unknowns of probiotics. Nat Med 25(5):716–729. https://doi.org/10.1038/s41591-019-0439-x - DOI - PubMed

LinkOut - more resources